{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:56:32Z","timestamp":1782521792746,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jclinepi.2019.10.016","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:14:33Z","timestamp":1584965673000},"page":"27-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Controversy and Debate on Meta-epidemiology. Paper 1: Treatment effect sizes vary in randomized trials depending on the type of outcome measure"],"prefix":"10.1016","volume":"123","author":[{"given":"Dorthe B.","family":"Berthelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ginnerup-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rn","family":"Hr\u00f3bjartsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Voshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2019.10.016_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jclinepi.2014.06.020","article-title":"Subjective and objective outcomes in randomized clinical trials: definitions differed in methods publications and were often absent from trial reports","volume":"67","author":"Moustgaard","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib3","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1136\/bmj.e1119","article-title":"Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"344","author":"Hrobjartsson","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jclinepi.2019.10.016_bib4","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1503\/cmaj.120744","article-title":"Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors","volume":"185","author":"Hrobjartsson","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jclinepi.2011.01.008","article-title":"Placebo effect studies are susceptible to response bias and to other types of biases","volume":"64","author":"Hrobjartsson","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovic","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib9","doi-asserted-by":"crossref","first-page":"e0159267","DOI":"10.1371\/journal.pone.0159267","article-title":"Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies","volume":"11","author":"Page","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib10","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.J.00850","article-title":"Comparison of patient-reported and clinician-assessed outcomes following total knee arthroplasty","volume":"93","author":"Khanna","year":"2011","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.jclinepi.2019.10.016_bib11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3324\/haematol.2013.093724","article-title":"Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia","volume":"99","author":"Efficace","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib12","first-page":"1967","article-title":"Determinants of discordance between patients and physicians in their assessment of lupus disease activity","volume":"30","author":"Yen","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bmj.39560.759572.BE","article-title":"Doctors' versus patients' global assessments of treatment effectiveness: empirical survey of diverse treatments in clinical trials","volume":"336","author":"Evangelou","year":"2008","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jclinepi.2019.10.016_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/rheumatology\/keh152","article-title":"Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy","volume":"43","author":"Cohen","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence--indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 3","key":"10.1016\/j.jclinepi.2019.10.016_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET Handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","article-title":"Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0","volume":"67","author":"Boers","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jclinepi.2003.12.010","article-title":"Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials","volume":"57","author":"Boutron","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib20","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jclinepi.2019.10.016_bib21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.2010.135129","article-title":"European League against Rheumatism recommendations for the inclusion of patient representatives in scientific projects","volume":"70","author":"de Wit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bjsports-2015-095741","article-title":"Physiotherapy for pain: a meta-epidemiological study of randomised trials","volume":"50","author":"Ginnerup-Nielsen","year":"2016","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib23","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib24","series-title":"Cochrane Handbook for systematic reviews of interventions. [Chapter 8]","author":"Higgins","year":"2008"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib25","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib26","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/sim.1184","article-title":"Statistical methods for assessing the influence of study characteristics on treatment effects in \u2018meta-epidemiological\u2019 research","volume":"21","author":"Sterne","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib30","series-title":"International Statistical Classification of Diseases and Related Health Problems 10th Revision","year":"2016"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib31","series-title":"Policy statement: Description of physical therapy","year":"2011"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib32","first-page":"9","article-title":"American Therapy Association. Physical therapy","volume":"81","year":"2001","journal-title":"Phys Ther"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib34","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/jnci\/djp386","article-title":"Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes","volume":"101","author":"Basch","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jclinepi.2019.10.016_bib35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.clon.2016.02.011","article-title":"The Cambridge breast intensity-modulated radiotherapy trial: comparison of clinician- versus patient-reported outcomes","volume":"28","author":"Mukesh","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib36","doi-asserted-by":"crossref","first-page":"f457","DOI":"10.1136\/bmj.f457","article-title":"Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study","volume":"346","author":"Ciani","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib37","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.295.19.2270","article-title":"Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005","volume":"295","author":"Ridker","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jclinepi.2016.02.012","article-title":"Evidence-based medicine has been hijacked: a report to David Sackett","volume":"73","author":"Ioannidis","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/bmj.326.7383.252","article-title":"Discrepancies between patients' assessments of outcome: qualitative study nested within a randomised controlled trial","volume":"326","author":"Campbell","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jclinepi.2010.08.009","article-title":"Reported quality of randomized controlled trials of physiotherapy interventions has improved over time","volume":"64","author":"Moseley","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.10.016_bib41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jclinepi.2008.09.018","article-title":"Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy","volume":"62","author":"Moseley","year":"2009","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435618310515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435618310515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:16:59Z","timestamp":1760246219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435618310515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":40,"alternative-id":["S0895435618310515"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2019.10.016","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversy and Debate on Meta-epidemiology. Paper 1: Treatment effect sizes vary in randomized trials depending on the type of outcome measure","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2019.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}